Sotera Health Company $SHC Shares Bought by Sculptor Capital LP

Sculptor Capital LP grew its stake in shares of Sotera Health Company (NASDAQ:SHC) by 57.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 21,000,000 shares of the company’s stock after purchasing an additional 7,658,200 shares during the quarter. Sotera Health makes up about 3.8% of Sculptor Capital LP’s holdings, making the stock its 4th largest position. Sculptor Capital LP owned about 0.07% of Sotera Health worth $370,440,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after buying an additional 2,756,583 shares during the last quarter. Sachem Head Capital Management LP lifted its position in shares of Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after buying an additional 3,735,000 shares during the last quarter. State Street Corp lifted its position in shares of Sotera Health by 21.0% in the 4th quarter. State Street Corp now owns 5,965,326 shares of the company’s stock worth $105,228,000 after buying an additional 1,035,457 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Sotera Health by 11.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,160,594 shares of the company’s stock worth $91,036,000 after buying an additional 524,012 shares during the last quarter. Finally, Two Seas Capital LP lifted its position in shares of Sotera Health by 30.8% in the 4th quarter. Two Seas Capital LP now owns 4,412,106 shares of the company’s stock worth $77,830,000 after buying an additional 1,038,878 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 15.36% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on SHC. Piper Sandler restated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research report on Friday, June 5th. They issued a “buy” rating and a $20.00 price target on the stock. Weiss Ratings downgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Finally, Barclays reduced their price target on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Eight analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.29.

Sotera Health Trading Up 0.2%

Shares of NASDAQ:SHC opened at $16.23 on Tuesday. The company has a market cap of $4.63 billion, a PE ratio of 39.59 and a beta of 1.79. The company’s 50-day moving average price is $15.63 and its 200 day moving average price is $16.37. Sotera Health Company has a fifty-two week low of $10.80 and a fifty-two week high of $19.85. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. Sotera Health’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period last year, the firm posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Sell-side analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.